Pages that link to "Q43953873"
Jump to navigation
Jump to search
The following pages link to Increased methotrexate toxicity due to concurrent probenecid administration (Q43953873):
Displaying 10 items.
- Resistance to antifolates (Q35567272) (← links)
- Clinically significant drug-drug interactions between oral anticancer agents and nonanticancer agents: profiling and comparison of two drug compendia. (Q37334707) (← links)
- Pharmacokinetic drug interactions of commonly used anticancer drugs. (Q38164714) (← links)
- Protein binding drug displacement interactions fact or fiction? (Q38631251) (← links)
- Methotrexate guidelines--revised (Q40326046) (← links)
- Methotrexate and other chemotherapeutic agents used to treat psoriasis. (Q41095005) (← links)
- Hepatic and biliary transport of orotate and its metabolic consequences (Q41668320) (← links)
- Probenecid inhibition of methotrexate excretion from cerebrospinal fluid in dogs (Q44054597) (← links)
- Selective availability of protein bound estrogen and estrogen conjugates to the rat kidney (Q57677427) (← links)
- Interaction between trimethoprim-sulfamethoxazole and methotrexate in children with leukemia (Q68588910) (← links)